Glenmede Trust Company »

Capricor Therapeutics shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $926k 32k 28.86

More positions owned by Glenmede Trust Company

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Ishares Tr Rusel 2500 Etf (SMMD)
Putnam Etf Trust Focused Lar Cap (PVAL)
Johnson & Johnson (JNJ)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Oracle Corporation (ORCL)

View all positions for Glenmede Trust Company

Top funds holding Capricor Therapeutics

BlackRock
Susquehanna International
Vanguard Group
Point72 Asset Management
Citadel Advisors
Suvretta Capital Management
Tang Capital Management
RA Capital Management
Geode Capital Management
FMR
J. Goldman & Co
Caption Management
State Street Corporation
Darwin Global Management
Millennium Management

View all funds holding Capricor Therapeutics